Dihydroartemisinin
-Plant extracts
Dihydroartemisinin
1.High quality plant extracts;
2.Organic and Natural；
3.Better stability.
Share the product
Product information
Dihydroartemisinin API
Basic Properties
CAS No.:71939-50-9
Dihydroartemisinin is semi-synthetic artemisinin derivative antimalarial API, effectively inhibiting plasmodium for malaria treatment. White crystalline powder, purity ≥99.0%, meets CP/EP/USP standards. Store sealed at 15–25°C away from light and moisture. Every batch provides full COA, HPLC, residual solvent and heavy metal test reports.
Production Technology
Derived from artemisia annua via catalytic hydrogenation synthesis. Multi-step recrystallization purification following ICH Q7, strictly controlling impurities. Complete stability documents support global drug registration.
Core Advantages
High antimalarial activity with low clinical dosage. Stable bulk supply for domestic and overseas generic drug factories. Complete DMF, GMP audit files to assist overseas registration. Flexible orders including lab samples, medium batches and large tender bulk with competitive prices.
Application Fields
- Prescription antimalarial oral tablets, dispersible tablets and compound malaria therapeutic preparations
- Pharmaceutical raw material for malaria finished medicines
Storage & Operation
Inner aluminum foil bag + fiber drum packaging, cool dry warehouse with RH ≤60%, far from high temperature. Wear dust-proof gloves and masks during sampling and mixing, separate from food & cosmetic raw materials.
Our Advantages
Sufficient long-term stock, full set of test and registration documents. Support trial samples and bulk wholesale orders.
Related raw material link: Red Clover P.E.
Global pharmaceutical compliance standard: FDA Official Portal